INFOARK INTERNATIONAL CO., LIMITED（北京信达和众国际贸易有限公司） is a Beijing-based enterprise engaged in global pharmaceutical trade, offering a comprehensive portfolio that spans active pharmaceutical ingredients (APIs), pharmaceutical intermediates, finished dosage forms, and health & nutrition products. Established with a strong foundation in international commerce and R&D integration, the company has developed a solid reputation as a strategic partner in pharmaceutical supply chains, with notable contributions in both human and veterinary health sectors.
Core Business
INFOARK specializes in the import and export of pharmaceutical raw materials and finished products. Its core operations include:
- Active Pharmaceutical Ingredients (APIs): Catering to both human and veterinary applications, the company supplies APIs aligned with stringent international regulatory standards.
- Pharmaceutical Intermediates: High-value intermediates such as Edoxaban, Apixaban, Liraglutide, and Gliclazide form a substantial part of its product offerings.
- Finished Dosage Forms (FDFs): INFOARK provides capsules, tablets, injections, and large-volume parenterals to international clients, catering to diverse therapeutic needs.
- Health and Nutrition Products: INFOARK also exports a range of plant extracts including grape seed extract, bilberry extract, ginkgo biloba extract, and white kidney bean extract, targeting the global nutraceutical market.
Specialization and Unique Value Proposition
INFOARK differentiates itself through its strong emphasis on research-driven sourcing, regulatory compliance, and long-term joint production partnerships. Its operational model is geared toward delivering consistent quality, backed by a robust network of audited manufacturing facilities and logistics partners across China. The company’s ability to integrate OEM (Original Equipment Manufacturing) capabilities allows global pharmaceutical companies to contract INFOARK for custom production and sourcing needs, reducing supply chain volatility and compliance risks.
Financial and Export Performance
While detailed private financial records are not publicly disclosed, INFOARK has demonstrated robust international trade activity. According to data from ImportYeti and Volza, INFOARK has executed over 280 documented international shipments, primarily targeting clients in India, the United States, and European Union nations. Key exports include high-volume APIs and specialized nutraceutical extracts, with shipment values reaching significant thresholds—several exceeding USD 100,000 per consignment, especially in the cardiovascular and metabolic therapeutic categories.
Target Markets
INFOARK serves pharmaceutical manufacturers, contract research organizations, and nutraceutical companies across:
- North America
- South and Southeast Asia
- European Union
- Middle East & North Africa (MENA)
The company has customized offerings to meet region-specific regulatory and market demands, including CEP, USDMF, and WC certification support where applicable.
Operational Capabilities
- Advanced Sourcing Network: Direct access to over 100+ GMP-certified production partners across China.
- Regulatory Expertise: Strong support for documentation and compliance including DMF filings, audit support, and regulatory inspections.
- OEM & Joint Production: INFOARK acts as a strategic manufacturing and export partner for clients looking to develop new markets through private labeling or joint ventures.
- Cold Chain & Hazardous Goods Logistics: Experienced in handling sensitive pharmaceutical and nutraceutical consignments globally.
Certifications and Compliance
While specific GMP certifications are held by partner manufacturers, INFOARK ensures all its sourced materials are compliant with major health authorities, including:
- China NMPA
- EU EMA standards
- US FDA filings (for supported APIs)
- WHO GMP, where applicable
INFOARK is also reputed for providing technical dossiers and CoAs (Certificate of Analysis) in standardized formats accepted globally.
Major Achievements
- Successful delivery of over 280+ international consignments across 25+ countries.
- Strategic long-term partnerships with pharmaceutical leaders in India and Southeast Asia.
- Recognized by several clients for on-time delivery and regulatory support efficiency, particularly during the COVID-19 supply chain crisis.
Client Feedback & Testimonials
Though detailed public testimonials are limited, several industry import databases record repeat purchases and steady supplier ratings, implying high client satisfaction. Notably, INFOARK has recurring export entries for the same clients, reflecting trust and reliability.
